New use of Corneal Tattooing to Treat Debilitating Negative Dysphotopsia after Cataract Surgery | ASCRS

Important Alert

2021 ASCRS Annual Meeting Announcement

Registration is Open

Registration and Housing for the 2021 ASCRS and ASOA Annual Meetings is Open!

Register now to attend the 2021 ASCRS Annual Meeting, featuring:
- Essential education and the latest in clinical techniques
- Inspiring speakers, expert faculty, and distinguished lecturers
- An Exhibit Hall with the latest industry trends from more than 200 companies
- Unparalleled opportunities to connect with friends, colleagues, and mentors
- ASOA practice management education for all members of the practice

The Early Bird Registration deadline is April 30 for the meeting being held in person July 23–27 in Las Vegas, Nevada!
Menu
Home Clinical Education Cornea New use of Corneal Tattooing to Treat Debilitating Negative Dysphotopsia after Cataract Surgery
Video
New use of Corneal Tattooing to Treat Debilitating Negative Dysphotopsia after Cataract Surgery
April 2018
Meeting: 2018 Annual Meeting
Presenters: Sophie J. Coutts, MD, Allon Barsam, MD, FRCOphth
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

Permanent ink can be used for cosmetic improvement in opaque corneas. This video also highlights its use in treating dysphotopsia in a post cataract surgery pseudophakic patient, who despite having excellent visual acuity was plagued with intractable symptoms of dysphotopsia.
Filed Under
Cornea dysphotopsia pseudophakic eye surgical technique 2018 film
View More Films

This film was submitted to the 36th Annual ASCRS Film Festival within the 2018 ASCRS ASOA Annual Meeting. 

View More 2018 Films
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2021 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.